Cargando…
Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides
BACKGROUND & AIMS: Many individuals are infected with hepatitis B virus (HBV) worldwide, and this virus is commonly controlled by treatments with interferon (IFN)-alpha and nucleoside analogues (NA). However, the complete elimination of HBV by these treatments is difficult and, thus, the develop...
Autores principales: | Yamamiya, Daisuke, Mizukoshi, Eishiro, Kaji, Kiichiro, Terashima, Takeshi, Kitahara, Masaaki, Yamashita, Tatsuya, Arai, Kuniaki, Fushimi, Kazumi, Honda, Masao, Kaneko, Shuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983448/ https://www.ncbi.nlm.nih.gov/pubmed/29856876 http://dx.doi.org/10.1371/journal.pone.0198264 |
Ejemplares similares
-
Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma
por: Kaji, Kiichiro, et al.
Publicado: (2017) -
Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8(+) T cells
por: Mizukoshi, Eishiro, et al.
Publicado: (2022) -
A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinoma
por: Tamai, Toshikatsu, et al.
Publicado: (2020) -
Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis
por: Terashima, Takeshi, et al.
Publicado: (2016) -
Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation
por: Kitahara, Masaaki, et al.
Publicado: (2020)